{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:19:26Z","timestamp":1770466766178,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-02868-w","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:02:10Z","timestamp":1720746130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nanosuspension-Based Repaglinide Fast-Dissolving Buccal Film for Dissolution Enhancement"],"prefix":"10.1208","volume":"25","author":[{"given":"Hamsa Yaseen","family":"Ghadhban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8526-0447","authenticated-orcid":false,"given":"Kawther Khalid","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"issue":"2","key":"2868_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/2231-4040.82950","volume":"2","author":"VR Patel","year":"2011","unstructured":"Patel VR, Agrawal YK. Nanosuspension: an approach to enhance the solubility of drugs. J Adv Pharm Technol Res. 2011;2(2):81\u20137.","journal-title":"J Adv Pharm Technol Res"},{"issue":"4","key":"2868_CR2","first-page":"35","volume":"2","author":"P Lakshmi","year":"2010","unstructured":"Lakshmi P, Kumar GA. Nanosuspension technology: a review. Int J Pharm Pharm Sci. 2010;2(4):35\u201340.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"7","key":"2868_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1211\/0022357023691","volume":"56","author":"VB Patravale","year":"2004","unstructured":"Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56(7):827\u201340.","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"2868_CR4","first-page":"771","volume":"12","author":"ZE Jassim","year":"2018","unstructured":"Jassim ZE, Rajab NA. Review on preparation, characterization, and pharmaceutical application of nanosuspension as an approach of solubility and dissolution enhancement. J Pharm Res. 2018;12(5):771\u20134.","journal-title":"J Pharm Res."},{"issue":"2","key":"2868_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/2230-973X.114897","volume":"3","author":"R Bala","year":"2013","unstructured":"Bala R, Pawar P, Khanna S, Arora S. Orally dissolving strips: a new oral drug delivery system approach. Int J Pharm Investig. 2013;3(2):67\u201376.","journal-title":"Int J Pharm Investig"},{"issue":"3","key":"2868_CR6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jpba.2006.01.056","volume":"41","author":"Z Mandi\u0107","year":"2006","unstructured":"Mandi\u0107 Z, Gabelica V. Ionization, lipophilicity and solubility properties of repaglinide. J Pharm Biomed Anal. 2006;41(3):866\u201371.","journal-title":"J Pharm Biomed Anal"},{"issue":"1\u20132","key":"2868_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijpharm.2013.04.032","volume":"450","author":"Y Gao","year":"2013","unstructured":"Gao Y, Liao J, Qi X, Zhang J. Coamorphous repaglinide-saccharin with enhanced dissolution. Int J Pharm. 2013;450(1\u20132):290\u20135.","journal-title":"Int J Pharm"},{"key":"2868_CR8","first-page":"377","volume":"10","author":"R Kavitha","year":"2012","unstructured":"Kavitha R, Sathali A. Enhancement of solubility of repaglinide by solid dispersion technique. Int J Chem Sci. 2012;10:377\u201390.","journal-title":"Int J Chem Sci"},{"key":"2868_CR9","doi-asserted-by":"crossref","unstructured":"Liu M, Cao W, Sun Y, He Z. Preparation, characterization, and in vivo evaluation of\u00a0formulation of repaglinide with hydroxypropyl-\u03b2-cyclodextrin. Int J Pharm. 2014;477(1\u20132):159\u201366.","DOI":"10.1016\/j.ijpharm.2014.10.038"},{"issue":"4","key":"2868_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1208\/s12249-014-0267-8","volume":"16","author":"R Gadadare","year":"2015","unstructured":"Gadadare R, Mandpe L, Pokharkar V. Ultra rapidly dissolving repaglinide nanosized crystals prepared via bottom-up and top-down approach: influence of food on pharmacokinetics behavior. AAPS PharmSciTech. 2015;16(4):787\u201399.","journal-title":"AAPS PharmSciTech"},{"key":"2868_CR11","first-page":"73","volume":"2","author":"H Khafeef","year":"2023","unstructured":"Khafeef H, Ayash N. Eplerenone crystal nanosuspension for solubility enhancement: preparation and evaluation. Maaen J Med Sci. 2023;2:73\u201380.","journal-title":"Maaen J Med Sci."},{"key":"2868_CR12","doi-asserted-by":"crossref","unstructured":"Muhesen RA, Rajab NA. Formulation and characterization of olmesartan medoxomil as a nanoparticle.\u00a0Res J Pharm Technol. 2023;16(7):3314\u20130.","DOI":"10.52711\/0974-360X.2023.00547"},{"issue":"8","key":"2868_CR13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.31351\/vol27iss1pp8-19","volume":"27","author":"IA Mohammed","year":"2018","unstructured":"Mohammed IA, Ghareeb MM. Investigation of solubility enhancement approach of ticagrelor. Iraqi J Pharm Sci. 2018;27(8):8\u201319.","journal-title":"Iraqi J Pharm Sci."},{"issue":"suppl","key":"2868_CR14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.31351\/vol32issSuppl.pp235-243","volume":"2","author":"RA Alzalzalee","year":"2023","unstructured":"Alzalzalee RA, Kassab HJ. Factors affecting the preparation of cilnidipine nanoparticles. Iraqi J Pharm Sci. 2023;2(suppl):235\u201343.","journal-title":"Iraqi J Pharm Sci."},{"issue":"02","key":"2868_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.25258\/ijddt.12.2.55","volume":"12","author":"Rasool ALobaidy RA, Rajab NA.","year":"2022","unstructured":"Rasool ALobaidy RA, Rajab NA. Preparation and in-vitro evaluation of darifenacin Hbr as nanoparticles prepared as nanosuspension. Int J Drug Deliv Technol. 2022;12(02):775\u201381.","journal-title":"Int J Drug Deliv Technol."},{"key":"2868_CR16","first-page":"1075","volume":"11","author":"N Toma","year":"2021","unstructured":"Toma N, Abdulrasool AA. Preparation and evaluation of microneedles-mediated transdermal delivery of montelukast sodium nanoparticles. Int J Drug Deliv Technol. 2021;11:1075\u201382.","journal-title":"Int J Drug Deliv Technol"},{"key":"2868_CR17","doi-asserted-by":"crossref","unstructured":"Al Hazzaa SA, Rajab NA. Cilnidipine nanocrystals, formulation and evaluation for optimization of solubility and dissolution rate. Iraqi J Pharm Sci. 2023;32(Suppl.):127\u201335.","DOI":"10.31351\/vol32issSuppl.pp127-135"},{"key":"2868_CR18","doi-asserted-by":"crossref","unstructured":"Ghyadh B, Al-khedairy E. Solubility and dissolution enhancement of atorvastatin calcium using phospholipid solid dispersion technique. Iraqi J Pharm Sci (P-ISSN 1683 - 3597 E-ISSN 2521 - 3512). 2023;32:244\u201353.","DOI":"10.31351\/vol32issSuppl.pp244-253"},{"issue":"11","key":"2868_CR19","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.52711\/0974-360X.2023.00868","volume":"16","author":"A Alezzy","year":"2023","unstructured":"Alezzy A, Al-Khedairy EBH. Preparation and evaluation of aceclofenac solid dispersion by fusion technique and effervescent assisted fusion technique: comparative study. RJPT. 2023;16(11):5358\u20135.","journal-title":"RJPT."},{"issue":"1","key":"2868_CR20","doi-asserted-by":"publisher","first-page":"2181747","DOI":"10.1080\/10717544.2023.2181747","volume":"30","author":"SA Fouad","year":"2023","unstructured":"Fouad SA, Teaima MH, Gebril MI, Abd Allah FI, El-Nabarawi MA, Elhabal SF. Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats. Drug Deliv. 2023;30(1):2181747.","journal-title":"Drug Deliv"},{"key":"2868_CR21","doi-asserted-by":"crossref","unstructured":"Mashru RC, Sutariya VB, Sankalia MG, Parikh PP. Development and evaluation of fast-dissolving film of salbutamol sulphate. Drug Dev Ind Pharm. 2005;31(1):25\u201334.","DOI":"10.1081\/DDC-200043947"},{"key":"2868_CR22","unstructured":"Gittings S. Development of biorelevant simulated salivary fluids for application in dissolution testing. PhD Thesis, University of Nottingham UK. 2016."},{"key":"2868_CR23","first-page":"387","volume":"12","author":"Z Kadhim","year":"2022","unstructured":"Kadhim Z, Rajab NA. Formulation and characterization of glibenclamide nanoparticles as an oral film. Int J Drug Deliv Technol. 2022;12:387\u201394.","journal-title":"Int J Drug Deliv Technol."},{"key":"2868_CR24","doi-asserted-by":"crossref","unstructured":"Chandramouli M,\u00a0 Shivalingappa\u00a0 RP, Basavanna V, Doddamani S, Shanthakumar DC, Nagarajaiah SR, Ningaiah S. Oral thin-films from design to delivery: a pharmaceutical viewpoint. Biointerface Res Appl Chem. 2022;13(2):177\u20130.","DOI":"10.33263\/BRIAC132.177"},{"key":"2868_CR25","doi-asserted-by":"crossref","unstructured":"Abbas IK, Rajab AN, Hussein A. Formulation and in-vitro evaluation of darifenacin hydrobromide as buccal films. Iraqi J Pharm Sci (P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512). 2019;28(2):83\u201394.","DOI":"10.31351\/vol28iss2pp83-94"},{"key":"2868_CR26","first-page":"321","volume":"12","author":"N Ayash","year":"2018","unstructured":"Ayash N. Preparation and characterization of lacidipine as an oral fast dissolving film. J Pharm Res. 2018;12:321\u20136.","journal-title":"J Pharm Res"},{"key":"2868_CR27","first-page":"1211","volume":"7","author":"S Bansal","year":"2014","unstructured":"Bansal S, Garg G. Design and optimization of fast dissolving film of losartan. Res J Pharm Technol. 2014;7:1211\u20138.","journal-title":"Res J Pharm Technol"},{"issue":"5","key":"2868_CR28","first-page":"249","volume":"10","author":"SA Jabir","year":"2017","unstructured":"Jabir SA, Sulaiman HT. Preparation and characterization of lafutidine as immediate release oral strip using different type of water-soluble polymer. J Appl Pharm. 2017;10(5):249\u201360.","journal-title":"J Appl Pharm."},{"issue":"1","key":"2868_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1208\/s12249-016-0496-0","volume":"18","author":"HO Ammar","year":"2017","unstructured":"Ammar HO, Ghorab MM, Mahmoud AA, Shahin HI. Design and In Vitro\/In Vivo evaluation of ultra-thin mucoadhesive buccal film containing fluticasone propionate. AAPS PharmSciTech. 2017;18(1):93\u2013103.","journal-title":"AAPS PharmSciTech"},{"key":"2868_CR30","doi-asserted-by":"crossref","unstructured":"Adnan TM, Hammid SN, Ahmed B. Formulation and in vitro evaluation of bromocriptine mesylate as fast dissolving oral film.\u00a0Int J Appl Pharm. 2018;10(1):7.","DOI":"10.22159\/ijap.2018v10i1.22615"},{"issue":"2","key":"2868_CR31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1208\/s12249-010-9425-9","volume":"11","author":"SA Tayel","year":"2010","unstructured":"Tayel SA, Soliman II, Louis D. Formulation of ketotifen fumarate fast-melt granulation sublingual tablet. AAPS PharmSciTech. 2010;11(2):679\u201385.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"2868_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0378-5173(98)00402-5","volume":"180","author":"CF Wong","year":"1999","unstructured":"Wong CF, Yuen KH, Peh KK. An in-vitro method for buccal adhesion studies: importance of instrument variables. Int J Pharm. 1999;180(1):47\u201357.","journal-title":"Int J Pharm"},{"issue":"4","key":"2868_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/17435390.2011.580863","volume":"6","author":"E Roblegg","year":"2012","unstructured":"Roblegg E, Fr\u00f6hlich E, Meindl C, Teubl B, Zaversky M, Zimmer A. Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa. Nanotoxicology. 2012;6(4):399\u2013413.","journal-title":"Nanotoxicology"},{"issue":"1\u20132","key":"2868_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpharm.2004.07.033","volume":"286","author":"MS El-Samaligy","year":"2004","unstructured":"El-Samaligy MS, Yahia SA, Basalious EB. Formulation and evaluation of diclofenac sodium buccoadhesive discs. Int J Pharm. 2004;286(1\u20132):27\u201339.","journal-title":"Int J Pharm"},{"key":"2868_CR35","first-page":"665","volume":"3","author":"M Mohamed","year":"2011","unstructured":"Mohamed M, Haider M, Ali M. Buccal mucoadhesive films containing antihypertensive drug: In vitro\/in vivo evaluation. J Chem Pharm Res. 2011;3:665\u201386.","journal-title":"J Chem Pharm Res"},{"key":"2868_CR36","unstructured":"Rashid Asmaa M, SNA-A. Formulation and Characterization of Itraconazole as Nanosuspension Dosage Form for Enhancement of Solubility Iraqi J Pharm Sci. 2019."},{"issue":"5","key":"2868_CR37","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1208\/s12248-016-9939-5","volume":"18","author":"SG Gumaste","year":"2016","unstructured":"Gumaste SG, Gupta SS, Serajuddin ATM. Investigation of polymer-surfactant and polymer-drug-surfactant miscibility for solid dispersion. AAPS J. 2016;18(5):1131\u201343.","journal-title":"AAPS J"},{"key":"2868_CR38","doi-asserted-by":"crossref","unstructured":"Attia MS, Elshahat A, Hamdy A, Fathi AM, Emad-Eldin M, Ghazy F-ES, Chopra H, Ibrahim TM. Soluplus\u00ae as a solubilizing excipient for poorly water-soluble drugs: recent advances in formulation strategies and pharmaceutical product features. J Drug Deliv Sci Technol. 2023;84:104519.","DOI":"10.1016\/j.jddst.2023.104519"},{"key":"2868_CR39","doi-asserted-by":"crossref","unstructured":"Abbas H K, Hussein Wais FM, Abood AN. Preparation and evaluation of ketoprofen nanosuspension using solvent evaporation technique. Iraqi J Pharm Sci (P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512). 2017:41\u201355.","DOI":"10.31351\/vol26iss2pp41-55"},{"issue":"1","key":"2868_CR40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.31351\/vol30iss1pp144-153","volume":"30","author":"RM Alwan","year":"2021","unstructured":"Alwan RM, Rajab NA. Nanosuspensions of selexipag: formulation, characterization, and in vitro evaluation. Iraqi J Pharm Sci. 2021;30(1):144\u201353.","journal-title":"Iraqi J Pharm Sci."},{"issue":"8","key":"2868_CR41","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/pharmaceutics12080732","volume":"12","author":"J Weng","year":"2020","unstructured":"Weng J, Tong HHY, Chow SF. In vitro release study of the polymeric drug nanoparticles: development and validation of a novel method. Pharmaceutics. 2020;12(8):732.","journal-title":"Pharmaceutics."},{"issue":"1\u20132","key":"2868_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijpharm.2014.10.025","volume":"477","author":"H Yang","year":"2014","unstructured":"Yang H, Teng F, Wang P, Tian B, Lin X, Hu X, et al. Investigation of a nanosuspension stabilized by soluplus (R) to improve bioavailability. Int J Pharm. 2014;477(1\u20132):88\u201395.","journal-title":"Int J Pharm."},{"issue":"6","key":"2868_CR43","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.4314\/tjpr.v15i6.2","volume":"15","author":"X-D Yang","year":"2016","unstructured":"Yang X-D, Li W-S, Tian Y-J, Liu C-G, Gao D-H, Ma H-L. Dissolution rate enhancement of repaglinide by solid dispersion. Trop J Pharm Res. 2016;15(6):1123\u20138.","journal-title":"Trop J Pharm Res."},{"issue":"1","key":"2868_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40199-015-0128-3","volume":"23","author":"HA Ebrahimi","year":"2015","unstructured":"Ebrahimi HA, Javadzadeh Y, Hamidi M, Jalali MB. Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants\/stabilizers on physicochemical properties of nanoparticles. DARU J Pharm Sci. 2015;23(1):46.","journal-title":"DARU J Pharm Sci."},{"issue":"1","key":"2868_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.15415\/jptrm.2020.81005","volume":"8","author":"S Gill","year":"2020","unstructured":"Gill S, Arora P. Improving physicochemical properties of repaglinide through pharmaceutical adduct formation. J Pharm Technol Res Manag. 2020;8(1):31\u20137.","journal-title":"J Pharm Technol Res Manag"},{"key":"2868_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4236\/snl.2015.52003","volume":"05","author":"S Patnaik","year":"2015","unstructured":"Patnaik S, Aditha SK, Rattan T, Kamisetti V. Aceclofenac-Soluplus&reg nanocomposites for increased bioavailability. Soft Nanosci Lett. 2015;05:13\u201320.","journal-title":"Soft Nanosci Lett"},{"issue":"2","key":"2868_CR47","first-page":"95","volume":"10","author":"SM Dizaj","year":"2015","unstructured":"Dizaj SM, Vazifehasl Z, Salatin S, Adibkia K, Javadzadeh Y. Nanosizing of drugs: effect on dissolution rate. Res Pharm Sci. 2015;10(2):95\u2013108.","journal-title":"Res Pharm Sci"},{"issue":"5","key":"2868_CR48","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s11095-022-03269-z","volume":"39","author":"RK Patel","year":"2022","unstructured":"Patel RK, Jonnalagadda S, Gupta PK. Use of flory-huggins interaction parameter and contact angle values to predict the suitability of the drug-polymer system for the production and stability of nanosuspensions. Pharm Res. 2022;39(5):1001\u201317.","journal-title":"Pharm Res"},{"issue":"12","key":"2868_CR49","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1080\/17458080.2016.1178402","volume":"11","author":"S Patnaik","year":"2016","unstructured":"Patnaik S, Chunduri LAA, Akilesh MS, Bhagavatham SS, Kamisetti V. Enhanced dissolution characteristics of piroxicam\u2013Soluplus\u00ae nanosuspensions. J Exp Nanosci. 2016;11(12):916\u201329.","journal-title":"J Exp Nanosci"},{"issue":"2","key":"2868_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/2230-973X.153387","volume":"5","author":"S Vidyadhara","year":"2015","unstructured":"Vidyadhara S, Sasidhar RL, Balakrishna T, Vardhan MS. Formulation of rizatriptan benzoate fast dissolving buccal films by emulsion evaporation technique. Int J Pharm Investig. 2015;5(2):101\u20136.","journal-title":"Int J Pharm Investig"},{"issue":"7","key":"2868_CR51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1208\/s12249-020-01811-z","volume":"21","author":"Z Al-Sahaf","year":"2020","unstructured":"Al-Sahaf Z, Raimi-Abraham B, Licciardi M, de Mohac LM. Influence of polyvinyl alcohol (PVA) on PVA-Poly-N-hydroxyethyl-aspartamide (PVA-PHEA) microcrystalline solid dispersion films. AAPS PharmSciTech. 2020;21(7):267.","journal-title":"AAPS PharmSciTech"},{"key":"2868_CR52","doi-asserted-by":"crossref","unstructured":"Asy-Syifa N. The study of the swelling degree of the PVA hydrogel with varying concentrations of PVA. J Phys: Conf Ser. 2022;2243(1):012053.","DOI":"10.1088\/1742-6596\/2243\/1\/012053"},{"issue":"11","key":"2868_CR53","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/pharmaceutics13111869","volume":"13","author":"AH Elshafeey","year":"2021","unstructured":"Elshafeey AH, El-Dahmy RM. Formulation and development of oral fast-dissolving films loaded with nanosuspension to augment paroxetine bioavailability: in vitro characterization, ex vivo permeation, and pharmacokinetic evaluation in healthy human volunteers. Pharmaceutics. 2021;13(11):1869.","journal-title":"Pharmaceutics."},{"issue":"1","key":"2868_CR54","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1080\/10717544.2020.1785582","volume":"27","author":"G Li","year":"2020","unstructured":"Li G, Lu Y, Fan Y, Ning Q, Li W. Enhanced oral bioavailability of magnolol via mixed micelles and nanosuspensions based on Soluplus(\u00ae)-Poloxamer 188. Drug Deliv. 2020;27(1):1010\u20137.","journal-title":"Drug Deliv"},{"key":"2868_CR55","doi-asserted-by":"publisher","first-page":"106417","DOI":"10.1016\/j.ejps.2023.106417","volume":"184","author":"JT Lynnerup","year":"2023","unstructured":"Lynnerup JT, Eriksen JB, Bauer-Brandl A, Hols\u00e6ter AM, Brandl M. Insight into the mechanism behind oral bioavailability-enhancement by nanosuspensions through combined dissolution\/permeation studies. Eur J Pharm Sci. 2023;184:106417.","journal-title":"Eur J Pharm Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02868-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-02868-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02868-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T23:35:36Z","timestamp":1732404936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-02868-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["2868"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-02868-w","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"161"}}